Botox A injection for pain after laparoscopic ventral hernia: a case report
Dustin Smoot1, Martin Zielinski, Donald Jenkins
1Mayo Clinic--Trauma, Critical Care and General Surgery, Rochester, MN 55905, USA. smoot.dustin@mayo.edu
Pain Medicine (Malden, Mass.)
|June 15, 2011
Summary
Botulinum toxin type A (Botox A) injections effectively managed severe postoperative pain following laparoscopic ventral hernia repair in a patient intolerant to narcotics. This novel approach significantly improved pain scores, offering a promising alternative for pain management.
Area of Science:
- Minimally invasive surgery
- Surgical pain management
- Gastrointestinal surgery
Background:
- Laparoscopic ventral hernia repair offers advantages in visualization and cosmesis over open techniques.
- Postoperative pain, particularly activity-limiting pain, remains a significant challenge.
- Narcotic pain medication intolerance necessitates alternative pain control strategies.
Observation:
- A novel technique using Botulinum toxin type A (Botox A) was employed for postoperative pain control.
- Botox A was diluted and injected into the external oblique, internal oblique, and transversus abdominal muscles.
- A total of 300 units of Botox A were administered across 18 injection sites.
Findings:
- The patient experienced a significant reduction in pain scores, decreasing from 10/10 to 2/10.
- Pain relief was sustained at a 3-month follow-up, indicating durable efficacy.
- Botox A provided substantial pain control after laparoscopic ventral hernia repair.
Implications:
- Botulinum toxin type A presents a viable alternative for managing refractory postoperative pain after hernia repair.
- Further prospective studies are warranted to establish long-term outcomes and cost-effectiveness.
- This technique may offer improved patient recovery and quality of life following abdominal wall reconstruction.
